{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:36:35Z","timestamp":1772706995320,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1124\/dmd.114.061812","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T07:29:32Z","timestamp":1416468572000},"page":"208-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Characterization of CYP2B6 in a CYP2B6-Humanized Mouse Model: Inducibility in the Liver by Phenobarbital and Dexamethasone and Role in Nicotine Metabolism In Vivo"],"prefix":"10.1016","volume":"43","author":[{"given":"Zhihua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.114.061812_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/00498251003713958","article-title":"Hepatic CYP2B6 is altered by genetic, physiologic, and environmental factors but plays little role in nicotine metabolism","volume":"40","author":"Al Koudsi","year":"2010","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.114.061812_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/FPC.0b013e3283527c1c","article-title":"CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people","volume":"22","author":"Binnington","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.114.061812_bib3","doi-asserted-by":"crossref","first-page":"e79700","DOI":"10.1371\/journal.pone.0079700","article-title":"CYP2B6 non-coding variation associated with smoking cessation is also associated with differences in allelic expression, splicing, and nicotine metabolism independent of common amino-acid changes","volume":"8","author":"Bloom","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1124\/dmd.114.061812_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3109\/00498254.2010.492880","article-title":"The in vitro metabolism of bupropion revisited: concentration dependent involvement of cytochrome P450 2C19","volume":"40","author":"Chen","year":"2010","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.114.061812_bib5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0090-9556(25)08797-5","article-title":"Phenobarbital and dexamethasone induce expression of cytochrome P-450 genes from subfamilies IIB, IIC, and IIIA in mouse liver","volume":"20","author":"Corcos","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.061812_bib6","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1124\/dmd.105.006718","article-title":"Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone metabolism by cytochrome P450 2B6","volume":"33","author":"Dicke","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.061812_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1124\/dmd.112.047118","article-title":"Quantitative prediction of CYP2B6 induction by estradiol during pregnancy: potential explanation for increased methadone clearance during pregnancy","volume":"41","author":"Dickmann","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.061812_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0026-895X(25)10836-5","article-title":"Immunochemical characterization of multiple forms of cytochrome P-450 in rabbit nasal microsomes and evidence for tissue-specific expression of P-450s NMa and NMb","volume":"37","author":"Ding","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.114.061812_bib9","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0026-895X(24)12054-8","article-title":"Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity","volume":"28","author":"Faucette","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.061812_bib10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1042\/bj2850979","article-title":"Regulation of the mouse liver cytochrome P450 2B subfamily by sex hormones and phenobarbital","volume":"285","author":"Honkakoski","year":"1992","journal-title":"Biochem J"},{"key":"10.1124\/dmd.114.061812_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clpt.2006.06.011","article-title":"Determinants of the rate of nicotine metabolism and effects on smoking behavior","volume":"80","author":"Johnstone","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.114.061812_bib12","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/mend.14.11.0547","article-title":"Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene","volume":"14","author":"Kawamoto","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1124\/dmd.114.061812_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bcp.2012.03.016","article-title":"Estradiol induces cytochrome P450 2B6 expression at high concentrations: implication in estrogen-mediated gene regulation in pregnancy","volume":"84","author":"Koh","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.114.061812_bib14","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1124\/jpet.103.054866","article-title":"Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression","volume":"307","author":"Lamba","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.114.061812_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/abbi.1994.1466","article-title":"The induction of five rat hepatic P450 cytochromes by phenobarbital and similarly acting compounds is regulated by a sexually dimorphic, dietary-dependent endocrine factor that is highly strain specific","volume":"315","author":"Larsen","year":"1994","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.114.061812_bib16","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1158\/1055-9965.EPI-07-0188","article-title":"CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy","volume":"16","author":"Lee","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1124\/dmd.114.061812_bib17","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.113.208256","article-title":"Impact of nicotine metabolism on nicotine\u2019s pharmacological effects and behavioral responses: insights from a Cyp2a(4\/5)bgs-null mouse","volume":"347","author":"Li","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.114.061812_bib18","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1093\/carcin\/bgu182","article-title":"Identification of cytochrome P450 enzymes critical for lung tumorigenesis by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): insights from a novel Cyp2abfgs-null mouse","volume":"35","author":"Li","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.114.061812_bib19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0090-9556(25)08198-X","article-title":"Characterization of cytochrome P-450 2B6 in human liver microsomes","volume":"21","author":"Mimura","year":"1993","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.061812_bib20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/138920009789895534","article-title":"Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6","volume":"10","author":"Mo","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.114.061812_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0090-9556(24)15152-5","article-title":"Use of a novel real-time quantitative reverse transcription-polymerase chain reaction method to study the effects of cytokines on cytochrome P450 mRNA expression in mouse liver","volume":"28","author":"Pan","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.061812_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/dmd.111.041368","article-title":"Bupropion hydroxylation as a selective marker of rat CYP2B1 catalytic activity","volume":"40","author":"Pekthong","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.061812_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.lfs.2006.09.015","article-title":"Comparative study of CYP2B induction in the liver of rats and mice by different compounds","volume":"80","author":"Pustylnyak","year":"2007","journal-title":"Life Sci"},{"key":"10.1124\/dmd.114.061812_bib24","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1074\/jbc.M412711200","article-title":"AMP-activated protein kinase mediates phenobarbital induction of CYP2B gene expression in hepatocytes and a newly derived human hepatoma cell line","volume":"280","author":"Rencurel","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.114.061812_bib25","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/01.fpc.0000220560.59972.33","article-title":"Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism","volume":"17","author":"Ring","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.114.061812_bib26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.114.061812_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1515\/dmdi-2012-0027","article-title":"Cytochrome P450 2B6: function, genetics, and clinical relevance","volume":"27","author":"Turpeinen","year":"2012","journal-title":"Drug Metabol Drug Interact"},{"key":"10.1124\/dmd.114.061812_bib28","doi-asserted-by":"crossref","unstructured":"Walsky RL and Obach RS (2009) Measurement of in vitro cytochrome P450 2B6 activity. Curr Protoc Toxicol Chapter 4:Unit4 27","DOI":"10.1002\/0471140856.tx0427s39"},{"key":"10.1124\/dmd.114.061812_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2174\/1389200033489262","article-title":"Transcriptional regulation of cytochrome p450 2B genes by nuclear receptors","volume":"4","author":"Wang","year":"2003","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.114.061812_bib30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/dmd.31.5.620","article-title":"Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes","volume":"31","author":"Wang","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.061812_bib31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2174\/138920008785821710","article-title":"CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme","volume":"9","author":"Wang","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.114.061812_bib32","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1021\/bi00337a023","article-title":"Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes","volume":"24","author":"Waxman","year":"1985","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.114.061812_bib33","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1124\/dmd.112.044826","article-title":"Generation and characterization of a CYP2A13\/2B6\/2F1-transgenic mouse model","volume":"40","author":"Wei","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.061812_bib34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejps.2004.04.012","article-title":"Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted","volume":"22","author":"Yamanaka","year":"2004","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.114.061812_bib35","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1021\/bi00444a029","article-title":"cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver","volume":"28","author":"Yamano","year":"1989","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.114.061812_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002040050588","article-title":"Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes","volume":"73","author":"Yamazaki","year":"1999","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.114.061812_bib37","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.1016\/S0021-9258(18)48254-3","article-title":"Suppression of levels of phenobarbital-inducible rat liver cytochrome P-450 by pituitary hormone","volume":"262","author":"Yamazoe","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.114.061812_bib38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0026-895X(24)12838-6","article-title":"Nuclear receptor CAR as a regulatory factor for the sexually dimorphic induction of CYB2B1 gene by phenobarbital in rat livers","volume":"59","author":"Yoshinari","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.114.061812_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fgene.2013.00024","article-title":"Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance","volume":"4","author":"Zanger","year":"2013","journal-title":"Front Genet"},{"key":"10.1124\/dmd.114.061812_bib40","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1124\/dmd.31.11.1346","article-title":"Characterization of mouse small intestinal cytochrome P450 expression","volume":"31","author":"Zhang","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.061812_bib41","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/jpet.107.127068","article-title":"CYP2A13: variable expression and role in human lung microsomal metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone","volume":"323","author":"Zhang","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.114.061812_bib42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1124\/dmd.114.061812_bib43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1124\/jpet.109.162610","article-title":"Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse model","volume":"332","author":"Zhou","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.114.061812_bib44","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1124\/dmd.114.060285","article-title":"Gene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomes","volume":"42","author":"Zhu","year":"2014","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624103467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624103467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.114.061812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:27:51Z","timestamp":1739906871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624103467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0090955624103467"],"URL":"https:\/\/doi.org\/10.1124\/dmd.114.061812","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of CYP2B6 in a CYP2B6-Humanized Mouse Model: Inducibility in the Liver by Phenobarbital and Dexamethasone and Role in Nicotine Metabolism In Vivo","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.114.061812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}